NURS 6630 PSYCHOPHARMACOLOGY MIDTERM EXAM PREP 2025/2026 ACCURATE QUESTIONS WITH CORRECT DETAILED ANSWERS || 100% GUARANTEED PASS LATEST VERSION

NURS 6630 PSYCHOPHARMACOLOGY MIDTERM EXAM PREP 2025/2026 ACCURATE QUESTIONS WITH CORRECT DETAILED ANSWERS || 100% GUARANTEED PASS LATEST VERSION 1. Noncompliance - ANSWER Patient refusal to follow prescribed treatment. 2. Neurotransmitter Imbalance - ANSWER Disruption in brain chemical levels affecting mood. 3. Positive Symptoms - ANSWER Symptoms that add to the patient's experience. 4. Mood stabilizers - ANSWER Treat both mania and bipolar depression symptoms. 5. Lithium (Lithobid) - ANSWER Requires regular blood tests for therapeutic monitoring. 6. TSH test - ANSWER Monitors thyroid function in patients on lithium. 7. Lamotrigine (Lamictal) - ANSWER May prevent progression of cognitive impairment. 8. Cognitive impairment - ANSWER Condition that may progress to Alzheimer's disease. 9. Weight gain concerns - ANSWER Common side effect of certain antidepressants. 10. Doxepin (Silenor) - ANSWER Sedating antidepressant with lower weight gain risk. 11. Lamotrigine - ANSWER Anticonvulsant linked to Stevens-Johnson syndrome. 12. Stevens-Johnson syndrome - ANSWER Severe skin reaction, potentially life-threatening. 13. FDA Approval - ANSWER Lamotrigine was among the first anticonvulsants approved. 14. Amenorrhea - ANSWER Absence of menstruation, risk in childbearing women. 15. Polycystic ovarian disease - ANSWER Hormonal disorder affecting women's reproductive system. 16. Carbamazepine - ANSWER Anticonvulsant with uncertain outcomes for depression. 17. Gabapentin - ANSWER Anticonvulsant with uncertain efficacy in depression treatment. 18. Valproic Acid - ANSWER Anticonvulsant with uncertain outcomes for bipolar depression. 19. Omega-3 fatty acids - ANSWER Alternative treatment not effective for bipolar depression. 20. Soybean lecithin - ANSWER Not recognized as a bipolar depression treatment. 21. Inositol - ANSWER Alternative agent, not effective for bipolar depression. 22. L-methylfolate - ANSWER Not indicated for treating bipolar depression. 23. Breastfeeding contraindication - ANSWER Valproic Acid is unsafe for nursing mothers. 24. Childhood mania symptoms - ANSWER Irritability and euphoria suggest possible conduct disorder. 25. Clozapine - ANSWER Medication for schizophrenia, affected by smoking. 26. Lorazepam - ANSWER Anxiolytic prescribed in lower doses for elderly. 27. Propranolol - ANSWER Beta blocker used for PTSD reconsolidation. 28. Clonazepam - ANSWER Benzodiazepine, requires careful weaning from treatment. 29. Citalopram - ANSWER SSRI used alongside Clonazepam for anxiety. 30. Medication side effects - ANSWER Heart issues may arise from certain psychiatric medications. 31. Alcohol abuse risk - ANSWER Higher in anxious patients due to coping mechanisms. 32. Cortisol - ANSWER Hormone increased by anxiety, linked to health risks. 33. Alcohol Abuse - ANSWER Higher risk in anxious patients due to self medication. 34. Self-Medication - ANSWER Using substances to cope with anxiety symptoms. 35. Flumazenil - ANSWER Medication used to reverse benzodiazepine effects. 36. Respiratory Depression - ANSWER Potential risk when administering flumazenil. 37. Escitalopram - ANSWER SSRI used to treat anxiety and depression. 38. SSRIs - ANSWER Selective Serotonin Reuptake Inhibitors for anxiety treatment. 39. Fear Conditioning - ANSWER Learning process where fear responses are established. 40. Propranolol - ANSWER Beta blocker used for PTSD symptom management. 41. Dopamine - ANSWER Neurotransmitter affected by atypical antipsychotics. 42. Atypical Antipsychotics - ANSWER Medications targeting dopamine and serotonin receptors. 43. Genetic Modification - ANSWER Genes can influence behavior and vice versa. 44. D2 Receptors - ANSWER Blocked by medications, affecting mood and behavior. 45. Gabapentin - ANSWER Anticonvulsant with uncertain outcomes for depression. 46. G-Protein Linked Receptors - ANSWER Most medications act as antagonists on these receptors. 47. Varenicline - ANSWER Medication prescribed for smoking cessation. 48. Comorbidities - ANSWER Co-occurring health conditions, like diabetes and anxiety. 49. Serotonin Increase - ANSWER Alcohol temporarily boosts serotonin, affecting mood. 50. Antidepressants - ANSWER Medications used prophylactically to prevent depression. 51. Panic Attacks - ANSWER Intense fear episodes often treated with SSRIs. 52. Withdrawal Symptoms - ANSWER Physical effects experienced after stopping substance use. 53. Beta Blockers - ANSWER Medications that reduce physical symptoms of anxiety. 54. Dopamine Hypothesis - ANSWER Theory linking dopamine to schizophrenia symptoms. 55. stimulation of a presynaptic neuron (e.g., by neurotransmitters, light, drugs, hormones, nerve impulses) causes electrical impulses to be sent to its axon terminal. These electrical impulses are then converted into chemical messengers and released to stimulate the receptors of a postsynaptic neuron. - ANSWER classic synaptic neurotransmission 56. is the gap between the presynaptic neuron and the postsynaptic neuron; it contains proteins and scaffolding and molecular forms of "synaptic glue" to reinforce the connection between the neurons. Receptors are present on both sides of this cleft and are key elements of chemical neurotransmission. - ANSWER The synaptic cleft 57. is the command center of the nerve and contains the nucleus of the cell - ANSWER the soma 58. Which type of Antipsychotics are preferred? Typical (first-generation) or Atypical (second generation): - ANSWER Atypical (second generation)